Medical device industry accelerator MedTech Innovator today announced about 50 medtech startups participating in its annual four-month program. Half are early-stage companies participating in MedTech Innovator’s Accelerator and Showcase program, and the other half are mid-stage companies in the organization’s Showcase program. The list of companies is a who’s who of people around the world […]
Ischemia Care
NeuroPace set to land at least $49M in latest round | Funding Roundup
NeuroPace, which is developing an implantable device to treat epilepsy and other neurological disorders, is on the verge of closing a large financing round, according to a regulatory filing
The Mountain View, Calif.-based firm has drummed up $49.1 million of a hoped-for $61.9 million round, according to the filing. A slew of names linked to venture capital firms are listed on the filing, from the likes of Kleiner Perkins Caufield & Byers, New Enterprise Associates, Angel Medical Systems, Cutlass Capital and Domain Associates.
Ischemia Care developing rapid stroke diagnostic
Don’t accuse molecular diagnostics startup Ischemia Care of thinking small.
The Oxford, Ohio-based company that was founded three years ago is hoping to be the first to market with a blood test to diagnose a stroke’s origin, the fourth-leading cause of death in the United States, and transient ischemic attacks, known as mini-strokes.
